← Leaderboards
Joseph G Jurcic
Sloan-Kettering Inst Can Research
$858,939
Attributed
$858,939
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $453.7K · FY2008–25$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$858,939 · 2
By mechanism
P30$453,660 · 1
P50$405,279 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Jan Grimm$17,140,928
- Gabriela Chiosis$23,584,161
- Archie N Tse$641,256
- Brett Stewart Carver$12,016,524
- Catherine E Mosher$4,930,574
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMonitorProtocols DocumentationClinical ResearchResearch StudyAntiangiogenesis Therapy17-(Allylamino)-17-DemethoxygeldanamycinCell Culture SystemCancer TherapyAntineoplastic AgentsAnimalsAttenuatedBaseBinding (Molecular Function)Carbonate DehydrataseBlood SpecimenBiopsyAntigensBone Marrow PurgingBone Marrow TransplantationCancer CellAffectAreaBiology